SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fabtech Technologies secures contract worth Rs 31.23 crore

15 Jun 2026 Evaluate

Fabtech Technologies has secured a contract worth Rs 31.23 crore for the critical internal infrastructure scope of a new Veterinary Vaccine Manufacturing Facility in Botswana. The project further strengthens the company’s growing presence across Africa’s healthcare, biotechnology, and vaccine manufacturing sectors. Under the project scope, the company will deliver advanced GMP-compliant internal infrastructure, precision HVAC systems, clean utilities, and critical MEP services engineered to international manufacturing standards. Fabtech will provide an integrated infrastructure platform designed for safe, efficient, and scalable vaccine production. 

Beyond veterinary healthcare, the project strengthens the company’s position within Africa’s emerging vaccine and biologics manufacturing ecosystem. The infrastructure being deployed today lays the foundation for broader capabilities in critical vaccines, biological products, and sterile injectable manufacturing across the continent, supporting Africa’s long-term ambition of healthcare and vaccine self-sufficiency.

Fabtech Technologies is a key turnkey engineering solution provider in pharmaceuticals capex space, offering comprehensive start to finish solutions encompassing designing, engineering, procurement, installation and testing of pharmaceutical equipment for a wide range of customers.

Fabtech Technologies Share Price

158.40 1.35 (0.86%)
23-Jun-2026 16:01 View Price Chart
Peers
Company Name CMP
Redington 275.00
Amrapali Industries 38.19
Adani Enterprises 2964.00
Rashi Peripheral 731.05
PDS 356.15
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: